Impaired synthesis of both telomere strands and adaptive TERT reduction in RTEL1 ATPase-dead cells
This study reveals that RTEL1 ATPase activity is essential for the synthesis of both telomere strands and that cancer cells adapt to its dysfunction by downregulating TERT expression to maintain survival, a mechanism that cannot be rescued by restoring the longest RTEL1 isoform alone.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every time a cell divides to make a new one, it must copy its entire library of genetic instructions. At the very ends of these instruction books are special protective caps called telomeres. Think of them as the plastic tips on shoelaces that keep the laces from fraying. In most normal cells, these caps get a little shorter with every division, eventually signaling the cell to stop dividing and retire. Cancer cells, however, are masters of immortality; they find a way to keep these caps from shrinking, allowing them to divide endlessly. To do this, they often reactivate a molecular machine called telomerase, which acts like a repair crew, adding fresh material to the ends of the caps to keep them long.
But the ends of our chromosomes are tricky places to copy. The DNA there is made of repeating patterns that have a strong tendency to tangle and fold into complex knots, much like a long, thin rope that refuses to lie flat. If the cell's copying machinery hits one of these knots, it can stall or break, leading to genetic chaos. A protein called RTEL1 is known to be a crucial worker in this difficult zone. Its job is to use energy to unwind these tangled DNA knots, clearing the path so the copying machine can pass through. Scientists have long suspected that if this worker stops working, the cell's telomeres would fall apart. However, the exact details of how this failure happens, and how a cancer cell might survive such a disaster, have remained a mystery.
Researchers at the University of Colorado Boulder decided to investigate this by creating a specific type of human cancer cell where the RTEL1 worker was broken. They used gene editing to change a single part of the protein so that it could no longer use energy to do its job, effectively turning it into a useless tool. They expected these cells to struggle, and they did. The cells grew much slower than normal and eventually stopped dividing. But when the scientists looked closer, they found something surprising that changed their understanding of how these cells survive.
The first thing they measured was how well the cells were building new telomeres. They used a special tag that gets incorporated into new DNA, allowing them to see exactly how much of the protective caps were being rebuilt. In the cells with the broken RTEL1, the production of new telomere material dropped by more than half. This confirmed that the protein is essential for building both sides of the telomere structure, not just one. The researchers also checked to see if the tangled DNA knots were piling up, which would be a sign that the worker was failing to clear the path. In other organisms, such as mice, this failure leads to a massive buildup of these knots. However, in these human cells, the knots did not pile up in the same way. The cells seemed to have found a different way to cope with the blockage.
The most unexpected discovery came when the scientists looked at the cell's internal instructions for making the repair crew. They found that the cells with the broken RTEL1 had drastically reduced the amount of instructions for telomerase, the machine that repairs the caps. In fact, the activity of this repair machine dropped by about 80 percent. This was counterintuitive. Usually, when a cell's telomeres are in trouble, it tries to make more repair crew to fix them. Here, the cell was doing the opposite: it was turning down the volume on the repair machine.
To test if this was a survival strategy, the researchers forced the cells to make a lot of telomerase again. They expected this to help the cells recover. Instead, it made things worse. The cells that were forced to produce high levels of the repair machine stopped growing entirely and got stuck in a specific phase of their division cycle. This suggested that the natural drop in repair activity was not a mistake, but a deliberate adaptation. By lowering the amount of repair crew, the cells were avoiding a dangerous conflict. It seems that when the path is blocked by the broken RTEL1 worker, trying to force the repair machine to work creates a traffic jam that the cell cannot survive. The cell survives by slowing down its own repair efforts to match the broken machinery.
The researchers also tested whether simply replacing the broken worker with a healthy version of the same protein could fix the problem. They introduced the longest, most common version of the RTEL1 protein back into the cells. Even though this new protein went to the right place and could still help lengthen the telomeres, it did not make the cells grow normally again. This indicates that the broken cells rely on other, less common versions of the protein to stay alive, and that fixing just the main version is not enough to restore health.
These findings reveal a complex and delicate balance in how cancer cells maintain their immortality. The study shows that when a key helper protein fails, the cell does not just panic and try to overcompensate. Instead, it adapts by lowering its expectations, reducing its repair activity to a level it can manage without crashing. This discovery suggests that the relationship between the worker that clears the path and the machine that repairs the ends is far more interconnected than previously thought. For scientists looking to develop new cancer treatments, this means that simply trying to block one part of the system might not work if the cancer cell has already learned to adapt by turning down another part. Understanding these hidden survival tricks could be the key to finding new ways to stop cancer cells from dividing forever.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.